Literature DB >> 25537818

Long-term outcomes of observation for clinically negative central compartment lymph nodes in papillary thyroid carcinoma.

Jie Liu1, Zhengang Xu1, Zhengjiang Li1, Zongmin Zhang1, Pingzhang Tang1, Shaoyan Liu2,3.   

Abstract

The treatment strategy for clinically negative lymph nodes of papillary thyroid carcinoma is controversial. We report the long-term outcomes of a series of cases treated with thyroidectomy without prophylactic central neck dissection. We reviewed 1,397 cases with papillary thyroid carcinoma treated at our institution between 1991 and 2000. One hundred and seventy-two newly diagnosed cases underwent observation for cN0 central neck lymph nodes. Regional recurrence of the ipsilateral side including central compartment and the lateral neck which needs reoperation was considered as key point for analysis. With a mean follow-up of 96.4 months (34-204 months), the overall 10-year disease-specific and recurrence-free survival rates were 99 and 86 %, respectively. The recurrence and reoperation rates of the central compartment were 3 % (5/172) and 4 % (7/172), respectively. Univariate analysis showed that extrathyroidal extension was associated with regional recurrence (99 vs. 82 %; p = 0.002). Central compartment observation is safe in cN0 cases with papillary thyroid carcinoma, particularly in those without extrathyroidal extension.

Entities:  

Keywords:  Cervical neoplasm; Follow-up studies; Lymph nodes dissection; Papillary carcinoma; Recurrence

Mesh:

Year:  2014        PMID: 25537818     DOI: 10.1007/s00405-014-3453-0

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  13 in total

1.  Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer.

Authors:  David T Hughes; Matthew L White; Barbra S Miller; Paul G Gauger; Richard E Burney; Gerard M Doherty
Journal:  Surgery       Date:  2010-12       Impact factor: 3.982

2.  Prophylactic central neck dissection for papillary thyroid cancer.

Authors:  M Barczyński; A Konturek; M Stopa; W Nowak
Journal:  Br J Surg       Date:  2012-11-27       Impact factor: 6.939

3.  A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer.

Authors:  Aleksandra Popadich; Olga Levin; James C Lee; Stephanie Smooke-Praw; Kevin Ro; Maisam Fazel; Asit Arora; Neil S Tolley; Fausto Palazzo; Diana L Learoyd; Stan Sidhu; Leigh Delbridge; Mark Sywak; Michael W Yeh
Journal:  Surgery       Date:  2011-12       Impact factor: 3.982

4.  Does extracapsular extension impact the prognosis of papillary thyroid microcarcinoma?

Authors:  Nathalie Chéreau; Camille Buffet; Christophe Trésallet; Frederique Tissier; Jean-Louis Golmard; Laurence Leenhardt; Fabrice Menegaux
Journal:  Ann Surg Oncol       Date:  2014-01-07       Impact factor: 5.344

5.  Risk factors contributing to the difference in prognosis for papillary versus micropapillary thyroid carcinoma.

Authors:  Theodore Karatzas; Ioannis Vasileiadis; Stylianos Kapetanakis; Efthimios Karakostas; George Chrousos; Gregory Kouraklis
Journal:  Am J Surg       Date:  2013-06-19       Impact factor: 2.565

6.  Optimization of staging of the neck with prophylactic central and lateral neck dissection for papillary thyroid carcinoma.

Authors:  Dana M Hartl; Sophie Leboulleux; Abir Al Ghuzlan; Eric Baudin; Linda Chami; Martin Schlumberger; Jean-Paul Travagli
Journal:  Ann Surg       Date:  2012-04       Impact factor: 12.969

7.  Observation of clinically negative central compartment lymph nodes in papillary thyroid carcinoma.

Authors:  Iain J Nixon; Ian Ganly; Snehal G Patel; Luc G Morris; Frank L Palmer; Dorothy Thomas; R Michael Tuttle; Jatin P Shah; Ashok R Shaha
Journal:  Surgery       Date:  2013-12       Impact factor: 3.982

Review 8.  Management of papillary and follicular (differentiated) thyroid cancer: new paradigms using recombinant human thyrotropin.

Authors:  E L Mazzaferri; N Massoll
Journal:  Endocr Relat Cancer       Date:  2002-12       Impact factor: 5.678

9.  Nodal status of central lymph nodes as a negative prognostic factor for papillary thyroid carcinoma.

Authors:  Yoon Se Lee; Yun-Sung Lim; Jin-Choon Lee; Soo-Geun Wang; In-Ju Kim; Seok-Man Son; Dong Hoon Shin; Byung-Joo Lee
Journal:  J Surg Oncol       Date:  2013-05-02       Impact factor: 3.454

10.  Impact of routine unilateral central neck dissection on preablative and postablative stimulated thyroglobulin levels after total thyroidectomy in papillary thyroid carcinoma.

Authors:  Brian Hung-Hin Lang; Kai Pun Wong; Koon Yat Wan; Chung Yau Lo
Journal:  Ann Surg Oncol       Date:  2011-06-17       Impact factor: 5.344

View more
  2 in total

1.  High-Dose RAI Therapy Justified by Pathological N1a Disease Revealed by Prophylactic Central Neck Dissection for cN0 Papillary Thyroid Cancer Patients: Is it Superior to Low-Dose RAI Therapy?

Authors:  Lan Wei; Lin Bai; Lina Zhao; Tianyu Yu; Qingjie Ma; Bin Ji
Journal:  World J Surg       Date:  2019-05       Impact factor: 3.352

2.  The Application Value of the Central Lymph Node Metastasis Risk Assessment Model in Papillary Thyroid Microcarcinoma of Stage cN0: A Study of 828 Patients.

Authors:  Jinqiu Wang; Xianneng Sheng; Yongping Dai; Jiabo Zhang; Lihua Song; Yu Guo
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-10       Impact factor: 6.055

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.